Results 131 to 140 of about 25,204 (165)
Some of the next articles are maybe not open access.
Abstract LB106: Ultra-short ctDNA: A new paradigm for ctDNA liquid biopsy
Cancer ResearchAbstract Mononucleosomal ctDNA (mnctDNA, 157-bp, double-stranded) spearheads liquid biopsy (LB) for cancer detection, treatment and clinical care. The bottleneck of mnctDNA LB are low copy number of ctDNA and limit of detection of platform technologies.
Feng Li +8 more
openaire +1 more source
Adjuvant Immunotherapy Best for ctDNA+ Bladder Cancer
Cancer Discovery, 2021Abstract A liquid biopsy may help identify patients with operable urothelial cancer who stand to benefit from adjuvant immunotherapy. In the IMvigor010 study, patients who tested positive for circulating tumor DNA showed improvement in disease-free survival and overall survival if they received adjuvant atezolizumab instead of ...
openaire +2 more sources
ctDNA in the reading room: A guide for radiologists
European Journal of RadiologyLiquid biopsy with sequencing of circulating tumor DNA (ctDNA) is a minimally invasive method for sampling body fluids and offers a promising alternative to tissue biopsies that involve greater risks, costs, and time. ctDNA not only identifies actionable targets by revealing unique molecular signatures in cancer, but also may assess treatment response,
Hayes, Pearce +7 more
openaire +2 more sources
Postoperative ctDNA monitoring: a canary in a coalmine
Annals of Oncology, 2021M A, Lumish, N, Tarazona, Y Y, Janjigian
openaire +2 more sources
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Ca-A Cancer Journal for Clinicians, 2021Heather Parsons +2 more
exaly
Technical and biological constraints on ctDNA-based genotyping
Trends in Cancer, 2021Cameron Herberts, Alexander W Wyatt
exaly